Your browser doesn't support javascript.
loading
Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab.
Tachinami, Hidetake; Tomihara, Kei; Yamada, Shin-Ichi; Ikeda, Atsushi; Imaue, Shuichi; Hirai, Hideaki; Nakai, Hiromi; Sonoda, Tomoko; Kurohara, Kazuto; Yoshioka, Yukio; Hasegawa, Takumi; Naruse, Tomofumi; Niiyama, Takashi; Shimane, Tetsu; Ueda, Michihiro; Yanamoto, Souichi; Akashi, Masaya; Umeda, Masahiro; Kurita, Hiroshi; Miyazaki, Akihiro; Arai, Naoya; Hayashi, Ryuji; Noguchi, Makoto.
Afiliación
  • Tachinami H; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan. Electronic address: hidetake@med.u-toyama.ac.jp.
  • Tomihara K; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan; Division of Oral and Maxillofacial Surgery, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan.
  • Yamada SI; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Ikeda A; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Imaue S; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Hirai H; Division of Oral and Maxillofacial Surgery, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan.
  • Nakai H; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Sonoda T; Department of Public Health, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kurohara K; Department of Oral and Maxillofacial Surgery, Department of Clinical Sciences, Medical Life Science, Mie University, Graduate School of Medicine, Mie, Japan.
  • Yoshioka Y; Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Hasegawa T; Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Naruse T; Department of Clinical Oral Oncology, Unit of Translational Medicine, Course of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Niiyama T; Department of Clinical Oral Oncology, National hospital organization, Hokkaido Cancer Center, Sapporo, Japan.
  • Shimane T; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Ueda M; Department of Clinical Oral Oncology, National hospital organization, Hokkaido Cancer Center, Sapporo, Japan.
  • Yanamoto S; Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Akashi M; Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Umeda M; Department of Clinical Oral Oncology, Unit of Translational Medicine, Course of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kurita H; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Miyazaki A; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Arai N; Department of Oral and Maxillofacial Surgery, Department of Clinical Sciences, Medical Life Science, Mie University, Graduate School of Medicine, Mie, Japan.
  • Hayashi R; Department of Medical Oncology, Toyama University Hospital, Toyama, Japan.
  • Noguchi M; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Br J Oral Maxillofac Surg ; 61(4): 320-326, 2023 05.
Article en En | MEDLINE | ID: mdl-37061418

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Antineoplásicos Inmunológicos / Neoplasias de Cabeza y Cuello Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Oral Maxillofac Surg Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Antineoplásicos Inmunológicos / Neoplasias de Cabeza y Cuello Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Oral Maxillofac Surg Año: 2023 Tipo del documento: Article